Evolution of characteristics of MASLD with and without diabetes: A meta- analysis of placebo arms

Han Ah Lee, Hye Ah Lee, Hwi Young Kim
2024 · doi:10.21203/rs.3.rs-3847827/v1
preprint OA: closed CC-BY-4.0
📄 Open PDF View at publisher

Abstract

Abstract Background: We explored the changes in metabolic dysfunction-associated steatotic liver disease (MASLD) severity over time by analyzing data from the placebo arms of randomized controlled trials (RCTs), particularly in relation to the presence of diabetes. Methods: RCTs on MASLD that included a placebo arm were identified using a systematic search of the literature. The primary outcomes were the changes in hepatic steatosis and fibrosis. Results: The meta-analysis included 8 RCTs involving 386 patients without diabetes and 24 RCTs involving 637 patients with diabetes. The pooled estimate of mean change in steatosis grade by histology was -0.1 in patients without diabetes, and -0.37 in patients with diabetes (P=0.066). The mean change in fibrosis stage by histology was 0.05 in patients without diabetes, and -0.03 in patients with diabetes (P=0.359). The mean change in nonalcoholic fatty liver disease activity score was -0.55 in patients without diabetes, and -1.50 in patients with diabetes (P=0.100).The mean change in ALT (-20.22 IU/L vs. -4.48 IU/L) and AST (-10.67 IU/L vs. -2.58 IU/L) were significantly larger in patients without diabetes compared to those with diabetes (P <0.05). Conclusion: In the placebo arm, patients with diabetes showed greater improvement in liver steatosis than those without diabetes.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

References (47)

Source provenance

crossref
last seen: 2026-06-13T06:42:53.260688+00:00
europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-20T11:00:21.680559+00:00
License: CC-BY-4.0